News from Zyme and the companies we work with.
ELRIG UK elects Melanie Leveridge to lead the organisation as Chair
Drug discovery expert leads not-for-profit organisation to drive further collaboration between academia and biopharma industry Melanie to chair ELRIG Drug Discovery Digital 2020 from 6–16 October York, UK, 23 September [...]
Creavo Medical Technologies Appoints Martin Frost as Chairman
Key appointment forms part of Creavo’s strategy to scale the Company Creavo’s Corsens® technology developed to improve patient care pathway in cardiac diagnostics COVENTRY, UK, 23 September 2020: Creavo Medical Technologies [...]
ERS Genomics appoints Michael Arciero as Vice-President of Intellectual Property & Commercial Development
DUBLIN, Ireland, 22 September 2020: ERS Genomics Limited (“ERS”), which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property (IP) co-owned by Dr. Emmanuelle Charpentier, today announced [...]
OXGENE introduces TESSA Technology for robust and reproducible AAV manufacture at scale
Novel, plasmid-free manufacturing system reduces cost of goods and improves AAV quality to enable development of safer gene therapies 22 September 2020, Oxford, UK: OXGENE™, a biotechnology company designing and [...]
Owlstone Medical Announces Key Study Results on use of Breath Biopsy for Improved Detection of Liver Disease including NASH and NAFLD
Study results support Owlstone Medical’s development of breath-based diagnostic and prognostic tests for liver disease Data validates Owlstone Medical’s EVOC probe strategy for breath-based diagnostic test development Results published in [...]
Mogrify wins Life Science Innovation Award and Prof. Julian Gough named Academic Entrepreneur of the Year at Business Weekly Awards 2020
Mogrify recognized for furthering life science discovery for the benefit of human healthcare through direct cellular conversion technology Co-founder and CSO receives award celebrating his achievements in establishing Mogrify Cambridge, [...]
ERS Genomics announces agreement with Applied StemCell to commercialize CRISPR gene editing services and reagents
DUBLIN, Ireland, and Milpitas, CA USA, 15th Septemer 2020: ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property (IP) co-owned by Dr. Emmanuelle [...]
Bio-Rad Introduces StarBright Violet 515 Dye for Flow Cytometry
HERCULES, Calif.–September 14, 2020– Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of StarBright Violet 515 [...]
ERS Genomics provides comment on US patent office motions decisions in CRISPR/Cas9 interference case
DUBLIN, Ireland, 14 September 2020: ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property held by Dr. Emmanuelle Charpentier, has today provided comment on [...]
CombiGene and Cobra Biologics sign agreement to secure GMP production of plasmids for production of CombiGene’s gene therapy CG01
The agreement is part of preparations for GMP production of material for the first clinical study of CG01 Lund, Sweden and Keele, UK, 10 September 2020. Cobra Biologics (Cobra), part [...]
Evonetix and Analog Devices Collaborate on Third-Generation DNA Synthesis Platform
Collaboration will fast track the development and scale-up of Evonetix’s desktop DNA writer towards commercialisation and first product Technology will help facilitate the rapidly growing multibillion-dollar synthetic biology industry CAMBRIDGE, [...]
Dotmatics introduces eln.online to support research start-ups
Quick start electronic lab notebook helps start-ups capture experimental data, collaborate with ease and secure their IP from day one eln.online provides easy, scalable access to Dotmatics Studies Notebook Bishop’s [...]
